Abstract
Satoshi Miyamoto, Shuhei Egashira, Yuta Otomo, Daiichiro Ishigami, Akinari Sekine, Naoki Sawa, Yoshifumi Ubara, Wataro Tsuruta
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
The screening, diagnosis, and management of patients with autosomal dominant polycystic kidney disease: a national consensus statement from Taiwan
2024
Vascular complications in autosomal dominant polycystic kidney disease: perspectives, paradigms, and current state of play
2023
Presymptomatic screening for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease
2019
Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease
2022
Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: prevalence, risk of rupture, and management. A systematic review
2017
MR brain screening in ADPKD patients: to screen or not to screen?
2022
Polycystic kidney disease among 4,436 intracranial aneurysm patients from a defined population
2017
All patients with ADPKD should undergo screening for intracranial aneurysms: PRO
2024
Clinical features and prognosis of autosomal dominant polycystic kidney disease with cerebrovascular complications
2023
Mutation type and intracranial aneurysm formation in autosomal dominant polycystic kidney disease
2022
Characteristics and distribution of intracranial aneurysms in patients with autosomal dominant polycystic kidney disease compared with the general population: a meta-analysis
2023
Natural history of asymptomatic unruptured cerebral aneurysms evaluated at CT angiography: growth and rupture incidence and correlation with epidemiologic risk factors
2013
Rupture-associated changes of cerebral aneurysm geometry: high-resolution 3D imaging before and after rupture
2014
Cerebral aneurysm: de novo genesis and rupture within 15 days
2021
Risk profile of intracranial aneurysms: rupture rate is not constant after formation
2011
A digest from evidence-based Clinical Practice Guideline for Polycystic Kidney Disease 2020
2021
Japan Stroke Society Guideline 2021 for the Treatment of Stroke
2022
KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary
2025
Evolution from an infundibulum of the posterior communicating artery to a saccular aneurysm
2011
Small unruptured intracranial aneurysm verification study: SUAVe study, Japan
2010
Sporadic ADPKD-IFT140: absence of family history as an indicator of clinical mildness
2024
Importance of IFT140 in patients with polycystic kidney disease without a family history
2024
Autosomal dominant polycystic kidney disease prevalence among a racially diverse United States population, 2002 through 2018
2021
No additional external references are available.